Abdominal Obesity and Lipid Disorder. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Intervention 1: In the intervention group intervention, including aerobic endurance exercise three days a week for 30 sessions is that the duration of exercise sessions with each session 40 minutes in
Lifestyle
Treatment - Drugs
In the intervention group intervention, including aerobic endurance exercise three days a week for 30 sessions is that the duration of exercise sessions with each session 40 minutes in the first two w
In the control Group intervention including consisted of advice to refrain from eating fatty Food and having daily routine activities and information to the researcher in order to participate in Regu
Sponsors
Ahvaz Jundishapour University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
38 Years to 52 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: 1) abdominal circumference of 88 cm or waist-hip ratio of 0.85; 2) Not taking any drug, anti-fat, fiber and medicines such as lovastatin and wasting drug; 3) lack of regular physical activity during the past 6 months Exclusion criteria:1) Failure to participate in sporting events and the absence of more than 3 sessions; 2) participate in sporting events sporting events other than the study; 3) Regular participation in sports more than one day a week
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Wheight. Timepoint: Before and After. Method of measurement: Kilograme(kg).;Body mass Index. Timepoint: Before and After. Method of measurement: -.;Waist-hip ratio. Timepoint: Before and After. Method of measurement: -. | — |
Primary
| Measure | Time frame |
|---|---|
| Abdominal Circumference. Timepoint: Before and After Intervention. Method of measurement: Tape and centimeter.;Cholesterol. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.;Triglycirid. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.;High Density Lipoprotein. Timepoint: Before and After Intervention. Method of measurement: Mg/dl.;Low Density Lipoprotein. Timepoint: Before and After Intervention. Method of measurement: Mg/dl. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHeydarpoor Parvin
Jondishapour University of Ahvaz
Outcome results
None listed